Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Biotech innovation in a first-to-file world

Nature Biotechnology volume 30, pages 401–403 (2012)Cite this article

Subjects

You may win the race, but can you take home the prize?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. US Public Law 112-29 [HR 1249].

  2. 35 USC §§ 102 and 103.

  3. See US Public Law 112-29 at Section 3.

  4. 447 US 303 (1980).

  5. See Gottschalk v. Benson, 409 US 63 (1972)

  6. Case No. 10-1150, US (2012).

  7. 653 F.3d 1329, (Fed. Cir. 2011).

  8. In re Fisher et al., 421 F.3d 1365 (Fed. Cir. 2005).

  9. 421 F.3d 1365 (Fed. Cir. 2005).

  10. See, for example, Ariad Pharmaceuticals, Inc. et al. v. Eli Lilly and Company, 598 F.3d 1336 (Fed. Cir. 2010).

  11. Fiers v. Revel, 984 F.2d 1164 (Fed. Cir. 1993).

  12. See Billups-Rothenberg, Inc. v. Associated Regional and University Pathologists, Inc. et al., 642 F.3d 1031 (Fed. Cir. 2011), citing Ariad Pharmaceuticals, Inc. v. Eli Lilly and Company, 598 F.3d 1336 (Fed. Cir. 2010).

  13. See Centocor Ortho Biotech, Inc. and New York University v. Abbott Laboratories et al., 636 F.3d 1341 (Fed. Cir. 2011).

  14. 642 F.3d 1031 (Fed. Cir. 2011).

  15. 119 F.3d 1559 (Fed Cir. 1997).

  16. 636 F.3d 1341 (Fed. Cir. 2011).

  17. 598 F.3d 1336 (Fed. Cir. 2010).

  18. 561 F.3d 1351 (Fed Cir. 2009).

  19. In re Wands, 858 F.2d 731 (Fed. Cir. 1988).

  20. Ariad Pharmaceuticals, Inc. et al. v. Eli Lilly and Company, 598 F.3d 1336 (Fed. Cir. 2010).

Download references

Author information

Authors and Affiliations

  1. Jennifer A. Camacho is at Greenberg Traurig LLP, Boston, Massachusetts, USA.,

    Jennifer A Camacho

Authors
  1. Jennifer A Camacho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer A Camacho.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Camacho, J. Biotech innovation in a first-to-file world. Nat Biotechnol 30, 401–403 (2012). https://doi.org/10.1038/nbt.2204

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2204

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research